MESO
MESO clinical trials: MESOBLAST LTD
Every trial on ClinicalTrials.gov where MESOBLAST LTD is the lead sponsor or a listed collaborator, the trials it leads first, each labelled Lead or Collaborator. Phase, status and dates as registered.
- 42
- Trials linked
- 39
- As lead sponsor
- 3
- As collaborator
- 0
- Primary completions as lead sponsor, next 90 days
MESO on the catalyst calendar · MESO registry changes
- Primary completion Jul 2027Sponsor estimatePhase 3NCT06325566Efficacy and Safety of Rexlemestrocel-L Combined With HA* in Participants With Moderate to Severe Chronic Low Back PainMesoblast, Ltd. · Degenerative Disc DiseaseActive, not recruitingMESOLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Feb 28, 2028Sponsor estimatePhase 3NCT07568535A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase III Trial of Remestemcel-L-rknd Added to Ruxolitinib for Grade III-IV...Mesoblast, Ltd. · GVHD - Graft-Versus-Host DiseaseNot yet recruitingMESOLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Sep 15, 2014ActualPhase 3NCT01233960Evaluation of PROCHYMAL® for Treatment-refractory Moderate-to-severe Crohn's DiseaseMesoblast, Inc. · Crohn's DiseaseCompletedMESOLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion May 18, 2011ActualPhase 2NCT00877903Prochymal® (Human Adult Stem Cells) Intravenous Infusion Following Acute Myocardial Infarction (AMI)Mesoblast, Inc. · Myocardial InfarctionCompletedMESOLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 12, 2010ActualPhase 2NCT00690066PROCHYMAL® (Human Adult Stem Cells) for the Treatment of Recently Diagnosed Type 1 Diabetes Mellitus (T1DM)Mesoblast, Inc. · Type 1 Diabetes MellitusCompletedMESOLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Mar 9, 2009ActualPhase 2NCT00683722PROCHYMAL™ (Human Adult Stem Cells) for the Treatment of Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)Mesoblast, Inc. · Pulmonary Disease, Chronic ObstructiveCompletedMESOLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jul 2009ActualPhase 3NCT00543374Extended Evaluation of PROCHYMAL® Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's DiseaseMesoblast, Inc. · Crohn's DiseaseCompletedMESOLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Sep 15, 2014ActualPhase 3NCT00482092Evaluation of PROCHYMAL® Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's DiseaseMesoblast, Inc. · Crohn's DiseaseCompletedMESOLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jan 30, 2020ActualPhase 3NCT02032004Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart FailureMesoblast, Inc. · Chronic Heart FailureCompletedMESOLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Not registeredNo phase registeredNCT04456439Intermediate-size Expanded Access Program (EAP), Mesenchymal Stromal Cells (MSC) for Multisystem Inflammatory Syndrome in Children...Mesoblast International Sàrl · Multisystem Inflammatory Syndrome in Children (MIS-C) Associated With Coronavirus Disease (COVID-19)No longer availableMESOLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Apr 25, 2006ActualPhase 2NCT00284986Safety and Efficacy of Prochymal for the Salvage of Treatment-Refractory Acute GVHD ParticipantsMesoblast, Inc. · Graft Versus Host DiseaseCompletedMESOLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion May 15, 2020ActualPhase 3NCT02412735Placebo-controlled Study to Evaluate Rexlemestrocel-L Alone or Combined With Hyaluronic Acid in Participants With Chronic Low Back PainMesoblast, Ltd. · Degenerative Disc DiseaseCompletedMESOLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Apr 6, 2021ActualPhase 2NCT01781390Safety Study of Allogeneic Mesenchymal Precursor Cell Infusion in Myocardial InfarctionMesoblast, Inc. · Acute Myocardial InfarctionCompletedMESOLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jun 15, 2018ActualPhase 3NCT02652130Safety Follow-up of Treatment With Remestemcel-L in Pediatric Participants Who Have Failed to Respond to Steroid Treatment for Acute GVHDMesoblast, Inc. · Grade B Acute Graft Versus Host DiseaseCompletedMESOLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Apr 9, 2018ActualPhase 3NCT02336230A Prospective Study of Remestemcel-L, Ex-vivo Cultured Adult Human Mesenchymal Stromal Cells, for the Treatment of Pediatric...Mesoblast, Inc. · Grade B aGVHDCompletedMESOLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 26, 2008ActualPhase 3NCT00366145Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)Mesoblast, Inc. · Graft Versus Host DiseaseCompletedMESOLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jul 14, 2009ActualPhase 3NCT00562497Efficacy and Safety of Prochymal® Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus...Mesoblast, Inc. · Graft Versus Host DiseaseCompletedMESOLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jul 28, 2006ActualPhase 2NCT00136903Safety and Efficacy Study of Adult Human Mesenchymal Stem Cells to Treat Acute Graft Versus Host Disease (GVHD)Mesoblast, Inc. · Graft Vs Host DiseaseCompletedMESOLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Sep 2011ActualPhase 1/Phase 2NCT00702741Follow-up Study of Chondrogen® Delivered by Intra-Articular Injection Following MeniscectomyMesoblast International Sàrl · Recovery Following Partial Medial MeniscectomyCompletedMESOLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Apr 2008ActualPhase 1/Phase 2NCT00225095A Phase I/II Study of Chondrogen Delivered by Intra-Articular Injection Following MeniscectomyMesoblast International Sàrl · Recovery Following Partial Medial MeniscectomyCompletedMESOLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Not registeredNo phase registeredNCT04366830Intermediate-size Expanded Access Program (EAP), Mesenchymal Stromal Cells (MSC) for Acute Respiratory Distress Syndrome (ARDS) Due to...Mesoblast International Sàrl · Moderate to Severe Acute Respiratory Distress Syndrome Associated With COVID-19No longer availableMESOLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Sep 23, 2016ActualPhase 3NCT01854567P3 Study of Umbilical Cord Blood Cells Expanded With MPCs for Transplantation in Patients With Hematologic MalignanciesMesoblast, Ltd. · Acute Myelogenous LeukemiaCompletedMESOLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion May 2016ActualPhase 2NCT01851070A Multi-center Study a Single IV Infusion of Allogeneic MPCs in Patients With Rheumatoid Arthritis and Incomplete Response to at Least...Mesoblast, Ltd. · Rheumatoid ArthritisCompletedMESOLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jul 2013ActualPhase 2NCT01290367Safety and Preliminary Efficacy Study of Mesenchymal Precursor Cells (MPCs) in Subjects With Lumbar Back PainMesoblast, Ltd. · Degenerative Disc DiseaseCompletedMESOLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion May 2012ActualPhase 1/Phase 2NCT01106417Safety and Efficacy Study of NeoFuse in Subjects Undergoing Multi-Level Anterior Cervical Discectomy and FusionMesoblast, Ltd. · Cervical Degenerative Disc DiseaseCompletedMESOLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
Enrollment, interventions and the start and completion dates are locked on 25 rows here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.
Unlock with TrialScannerShowing the first 25 trials. There are 17 more in this window; the full list is part of TrialScanner.
Unlock with TrialScanner